Skip to main content

Table 6 Cox regression analysis on GC-related hospitalization, 2-level definition of corticosteroid treatment, including CCI (non-rheumatologic comorbidities vs rheumatologic comorbidities only)

From: Influence of initial glucocorticoid co-medication on mortality and hospitalization in early inflammatory arthritis: an investigation by record linkage of clinical and administrative databases

 

HR (95% CI)

Adj HR (95% IC)

No GC

Ref

Ref

GC

0.95 (0.65, 1.37)

1.08 (0.72, 1.61)

Female gender

-

0.41 (0.27, 0.60)

Age

-

1.07 (1.05, 1.09)

HAQ

-

1.34 (1.02, 1.76)

CCI >1

-

1.76 (1.14, 2.71)

MTX

-

1.06 (0.63, 1.80)

ACPA

-

1.58 (0.95, 2.61)

  1. GC glucocorticoid, HR hazard ratio, CI confidence interval, HAQ Health Assessment Questionnaire, CCI Charlson Comorbidity Index, MTX methotrexate, ACPA anti-cyclic citrullinated peptide antibodies